Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study

Cardiovascular Drugs and Therapy

Volumn 12, Issue 2, 1998, Pages 171-176

  Reicher Reiss, Henrietta ^a   Behar, Solomon ^a   Boyko, Valentina ^a   Mandelzweig, Lori ^a   Kaplinsky, Elieser ^a   Goldbourt, Uri ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Calcium channel blockers; Mortality; Myocardial infarction; Nifedipine

Indexed keywords

NIFEDIPINE;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ADULT; AGE FACTORS; AGED; CALCIUM CHANNEL BLOCKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NIFEDIPINE; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; RECURRENCE;

EID: 0031777275     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007779026915     Document Type: Article

References (30)

1. Braunwald E, Muller JE, Stone PH. Use of calcium channel blocking agents in the management of ischemic heart disease. Eur Heart J 1985;6(Suppl A):31-36.
2. Rick KR, Gervino E, Jarise WR, Stone PH. Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina. Am J Cardiol 1990;65:1097-1101.
3. Frishman WH, Rosenberg A, Katz B. Calcium antagonist in the management of systemic hypertension: The impact of sustained-release drug delivery systems. Cor Art Dis 1994; 5:4-13.
4. Taylor SH. Usefulness of amlodipine for angina pectoris. Am J Cardiol 1994;73:28A-33A.
5. Cone PF, Vetrovec GW, Nesto R, et al. The Nifedipine - Total Ischemia Awareness Program: A national survey of painful and painless myocardial ischemia including results of anti-ischemic therapy. Am J Cardiol 1984;63:534-539.
6. Yusuf S, Held PH, Furberg CD. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT II) and other recent studies. Am J Cardiol 1991;67:1295-1297.
7. Lichtlen PR, Hugenholtz PG, Raffenbuell W, Hecker H, Jost S, Deckers JW on behalf of the INTACT group. Retardation of angiographic progression of coronary artery disease by nifedipine: Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT) Lancet 1990;335: 1109-1113.
8. Psaty BM, Heckhert SR, Koepsell TD, et al. The risk of myocardial infarction associated with anti-hypertensive drug therapies. JAMA 1995;274:620-625.
9. Furberg CD, Psaty BM, Meyer JV. Nifedipine: Dose related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
10. Pahor M, Guralnik JM, Corti MC, Foley DJ, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Sac 1995;43:1191-1197.
11. The Israeli SPRINT Study Group. The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J 1988;9:354-364.
12. Cox DR. Regression models and life tables. J R Stat Soc 1972;B34:187-220.
13. Koenig W, Lowel H, Lewis M, Hormann A. Long-term survival after myocardial infarction: Relationship with thrombolysis and discharge medication. Eur Heart J 1996;17: 1199-1206.
14. Messerli FH. Case-control study, meta-analysis, and bouillabaisse: Putting calcium antagonist scare into context. Ann Intern Med 1995;123:888-889.
15. Calcium antagonist caution [Editorial] Lancet 1991;337: 885-886.
16. Lenfant C. The calcium channel blocker scare: Lessons for the future. Circulation 1995;91:2855-2856.
17. Kaplan NM. Do calcium antagonists cause myocardial infarction? Am J Cardiol 1996;77:81-82.
18. Kloner RA. Nifedipine in ischemic heart disease. Circulation 1995;92:1074-1078.
19. Yusuf S. Calcium antagonists in coronary artery disease and hypertension: Time for re-evaluation. Circulation 1995;92: 1079-1082.
20. Opie LH, Messerli FH. Nifedipine and mortality: Grave defects in the dossier. Circulation 1995;92:1068-1073.
21. Jackson G. Calcium antagonists: When the content does not justify the headline. Br J Clin Pharmacol 1995;19:283-284.
22. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction: The Danish Verapamil Infarction Trial II (DAVIT-II). Am J Cardiol 1990;66:779-785.
23. Multicenter Diltiazem Post Infarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-392.
24. Held PH, Yusuf S, Furberg CD. Calcium channel blocking agents in acute myocardial infarction and unstable angina: An overview. Br Med J 1989;299:1187-1192.
25. Goldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzweig L, Kaplinsky E, for the SPRINT Study Group. Early administration of nifedipine in suspected acute myocardial infarction. Arch Intern Med 1993;153:345-353.
26. Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Early treatment of unstable angina in the coronary care unit: A randomized, double-blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Br Heart J 1986;56:400-413.
27. Muller JE, Morrison J, Stone PH, et al. Nifedipine therapy for patients with threatened and acute myocardial infarction: A randomized, double-blind, placebo-controlled comparison. Circulation 1984;69:740-747.
28. Elkayam U, Amin J, Mehra A, Vasquez J, Weber L, Rahimtoola SH. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990;82:1954-1961.
29. Packer M, O'Connor CM, Ghali JK, et al. for the Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996;335:1107-1114.
30. Parmley WW. A delayed answer to the calcium blocker question. J Am Coll Cardiol 1996;27:510-511.